Atlas Trials

Isoniazid Dosage Prediction Model Development

Clinical trial NCT02747654 · UNKNOWN

Trial details

NCT number
NCT02747654
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
NAT2 Genotype
Start date
2014-06-01
Primary completion
2016-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.